Pfizer gains on receiving approval to incorporate wholly owned subsidiary

06 Jan 2012 Evaluate

Pfizer is currently trading at Rs. 1110.00, up by 12.30 points or 1.12% from its previous closing of Rs. 1097.70 on the BSE.

The scrip opened at Rs. 1110.00 and has touched a high and low of Rs. 1110.00 and Rs. 1110.00 respectively.

The BSE group 'B' stock of face value Rs. 10 has touched a 52 week high of Rs. 1636.20 on 28-Jul-2011 and a 52 week low of Rs. 1071.55 on 30-Dec-2011.

Last one week high and low of the scrip stood at Rs. 1115.00 and Rs. 1087.70 respectively. The current market cap of the company is Rs. 3,312.00 crore.

The promoters holding in the company stood at 70.75% while Institutions and Non-Institutions held 9.23% and 20.02% respectively.

Pfizer has received an approval for incorporation of a wholly owned subsidiary in the state of Maharashtra, with a view to spin off its animal health business to such entity as a pre-step to subsequent sale to a wholly owned subsidiary of Pfizer Inc., in India. The board at its meeting held on January 05, 2012 has discussed and approved for the same.

Further, the implementation of the above proposal would be subject to various approvals and permissions.

Recently, Pfizer had recalled Citalopram tablets, from the US market owing to wrong labeling. Citalopram tablets were manufactured by city-based Aurobindo Pharma. The latest recall, which was notified by the USFDA on August 17, involved 720 units of Citalopram tablets, USP, 10 mg, 100-count bottles.

Pfizer, a subsidiary of Pfizer Inc, is engaged in manufacturing of products like Protinex, Isonex, Becosules and Corex.

Pfizer Share Price

5222.05 92.95 (1.81%)
22-Nov-2024 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1797.80
Dr. Reddys Lab 1213.90
Cipla 1486.30
Lupin 2069.95
Zydus Lifesciences 948.70
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.